Regular insulin added to total parenteral nutrition vs subcutaneous glargine in non-critically ill diabetic inpatients, a multicenter randomized clinical trial: INSUPAR trial

Clin Nutr. 2021 Mar;40(3):1440. doi: 10.1016/j.clnu.2021.01.029. Epub 2021 Feb 7.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus*
  • Humans
  • Hypoglycemic Agents
  • Inpatients
  • Insulin Glargine
  • Insulin*
  • Parenteral Nutrition, Total

Substances

  • Hypoglycemic Agents
  • Insulin
  • Insulin Glargine